Research

Energy balance

Tirzepatide has a generally safe profile with possible mild-to-moderate gastrointestinal side effects.

Healthcare providers should monitor patients for gastrointestinal side effects when prescribing tirzepatide.

StrongSupportsmedium confidence
Clinicians should be aware of possible adverse events, mainly mild-to-moderate gastrointestinal side effects.
Ioannis Avgerinos et al. · Expert Opinion on Drug Discovery · 2024

Why this rating

Based on data from phase 3 clinical trials.

Source

The preclinical discovery and clinical evaluation of tirzepatide for the treatment of type 2 diabetes

Ioannis Avgerinos et al. · Expert Opinion on Drug Discovery · 2024

DOI 10.1080/17460441.2024.2324918

reviewCited 5×
Read the paper
DOI resolved against Crossref · corpus check 2026-06-10

This is one finding among thousands. Every one is graded and traced to its source, so you can see what the evidence actually supports. Browse the research →